Skip to content

Drug interactions

Eslicarbazepine + Rolapitant

Severity: Moderate

Eslicarbazepine and Rolapitant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine is a CYP3A4 inducer and may reduce rolapitant concentrations with prolonged use. The induction is weaker than that of carbamazepine but could reduce antiemetic efficacy.

What this interaction means in plain words

Eslicarbazepine and Rolapitant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eslicarbazepine belongs to Central Nervous System; Rolapitant belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Eslicarbazepine induces CYP3A4, increasing rolapitant metabolism.

What to do

Consider an alternative antiemetic not dependent on rolapitant. If combined, monitor for inadequate emesis control.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eslicarbazepine and Rolapitant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eslicarbazepine with Rolapitant?

MediHelp rates the interaction as moderate. Eslicarbazepine and Rolapitant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eslicarbazepine is a CYP3A4 inducer and may reduce rolapitant concentrations with prolonged use. The induction is weaker than that of carbamazepine but could reduce antiemetic efficacy.

How serious is the interaction between Eslicarbazepine and Rolapitant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider an alternative antiemetic not dependent on rolapitant. If combined, monitor for inadequate emesis control.

What other medicines interact with Rolapitant?

MediHelp also lists interactions of Rolapitant with, for example, Pimozide, Thioridazine, Atomoxetine. The full list is on the Rolapitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in